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http:WHAT THIS PAPER ADDS?
Even strongly cross-sectional associated the role of atherosclerosis in abdominal aortic dilatation and aneurysm
formation has been questioned. Prospective data in this area are spare. The new prospective data presented in
this study demonstrate an independent linear doseeresponse relationship between carotid plaque growth and
growth of abdominal aortic diameter. These observations suggest that atherosclerosis may explain some of the
variance in dilatation of the abdominal aorta and aneurysm formation. Identiﬁcation and aggressive treatment
of risk factors for atherosclerosis are recommended in patients with dilatation of the abdominal aorta.Objectives: This research aims to study how carotid atherosclerosis is related to growth of infrarenal aortic
diameter and aneurysmal formation.
Design: Population-based follow-up study.
Materials and methods: At baseline, ultrasound examination of the carotid artery and the abdominal aorta was
performed in 4241 persons from a general population with no evidence of abdominal aortic aneurysm (AAA). The
burden of atherosclerosis was assessed as carotid total plaque area (TPA). After a mean follow-up of 6.3 years,
a new ultrasound examination was performed and measurements of the aortic diameter and carotid TPA were
repeated. The effects on aortic diameter progression, follow-up diameter and risk for AAA were assessed in
multiple linear and logistic regression models according to carotid TPA, adjusted for known risk factors.
Results: When analysing AAA as a dichotomous variable, a borderline association between atherosclerosis and
AAA could be demonstrated.When modelling aortic diameter as a continuous variable, a 1-SD increase in 5 years’
carotid plaque area (DTPA) was associated with a 0.12-mm growth in infrarenal aortic diameter (standard error
(SE) 0.04) and a 0.20-mm wider aorta at follow-up (SE 0.06). No independent relation was seen for baseline
atherosclerosis.
Conclusions: Carotid plaque progression was positively related to growth in infrarenal aortic diameter and aortic
diameter at follow-up. Whether this co-variation between plaque growth and aortic diameter growth is causally
related or independent events is still an open question.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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//dx.doi.org/10.1016/j.ejvs.2012.11.019in the aneurysmal wall and in other circulatory beds is
a common ﬁnding in AAA patients.1,2 However, the aetio-
logical role of atherosclerosis in AAA has been ques-
tioned.3,4 The strong association between atherosclerosis
and AAA may be confounded by several shared risk factors,
smoking in particular, and also hypertension and hyper-
lipidaemia, although the strength of these associations
differs between the two diseases.5e12
Recent caseecontrol studies did not ﬁnd evidence for
more carotid, coronary or peripheral atherosclerosis in AAA
patients.13,14 In a previous cross-sectional population-based
study, we could not ﬁnd any consistent relationship
between total carotid plaque area (TPA) and maximal
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Neither were we able to demonstrate any correlation
between TPA and aneurysmal diameter in those with AAA.
However, an aortic diameter beyond 27 mm was associated
with increased burden of both carotid atherosclerosis
and coronary heart disease (CHD).15 Due to the cross-
sectional design of that study, no inferences could be made
whether atherosclerosis precedes aortic dilatation or vice
versa. In the present study of 4241 persons without AAA,
we prospectively examined how baseline carotid TPA
and carotid plaque growth (DTPA) were related to increase
in infrarenal aortic diameter, follow-up diameter and inci-
dent AAA.MATERIALS AND METHODS
Study population
The Tromsø Study was initiated in 1974 and is a population-
based, prospective study with six repeated health surveys
including total birth cohorts and random samples of the
inhabitants of the municipality of Tromsø, Norway.16 The
study has been approved by The Regional Committee for
Medical and Health Research Ethics and informed consent
was obtained from all participants. As a part of the fourth
survey in 1994/1995, a total of 6892 men and women, aged
25e84 years, underwent ultrasound scanning of the
abdominal aorta in order to measure the maximal diameter
of the infrarenal aorta. The attendance rate was 79%.17
Ultrasound of the carotid artery was also performed. In the
ﬁfth survey, conducted in 2001, 5087 (85%) of these
subjects attended the part of the study that included
ultrasound examination of the abdominal aorta. Persons
with a Y-graft were excluded (n ¼ 37). Baseline carotid TPA
and baseline and follow-up maximal infrarenal transversal
and anterioreposterior aortic diameters were available in
4326 persons. However, an AAA (deﬁned as the maximal
infrarenal aortic diameter 30 mm) was present at baseline
in 85 persons. They were excluded from this follow-up.
Thus, 4241 subjects (1995 men and 2246 women) aged 25e
82 years in 1994 were included in the present study.Cardiovascular risk factors
Information about smoking habits, angina pectoris,
myocardial infarction and use of anti-hypertensive drug was
collected from self-administered questionnaires. Informa-
tion about the use of lipid-lowering drugs (mainly statins)
was collected at the screening examination. The participants
were asked the following questions: “Do you have or did
you ever have angina pectoris (heart cramp)?” and “Do you
have or did you ever have a heart attack (myocardial
infarction)?” If the answer to either question was yes, the
participant was classiﬁed to have CHD. Standardised
measurements of height, weight, blood pressure and non-
fasting serum total cholesterol, high-density lipoprotein
(HDL)-cholesterol and triglycerides were performed as
described previously.11Ultrasonography of the abdominal aorta and carotid
artery
The ultrasonographic measurements of the abdominal aorta
have been described in detail previously.11,17 The maximal
infrarenal aortic diameter was in the present analyses
deﬁned as the mean of the maximal transversal and ante-
rioreposterior diameters. The difference between inter-
and intra-observer variability of the maximal aortic diam-
eter in the ultrasound examination at baseline was 4 mm
in 95% of the pairs.17 At follow-up in 2001, the corre-
sponding ﬁgures were 87% and 96%.12 An incident AAA was
deﬁned as follow-up maximal infrarenal aortic diameter
30 mm or as gone through surgery on the abdominal
aorta due to aneurysm between baseline and follow-up
screening.
The carotid ultrasound examination was carried out as
detailed elsewhere.18,19 A plaque was deﬁned as a localised
protrusion of the vessel wall into the lumen of at least 50%
compared to the adjacent intimaemedia thickness. In each
subject, a maximum of six plaques were registered in the
near and far walls of the common carotid artery (CCA),
bifurcation and internal carotid artery (ICA), respectively.
Digitalised longitudinal plaque images were transferred to
and standardised in Adobe Photoshop, to calculate the
plaque area.20 In subjects with more than one plaque, the
areas of all plaques were summarised to give the TPA.Statistical analyses
As the follow-up differed somewhat between the individ-
uals, we calculated the estimated change per 5 years and
included this variable in the analysis instead of the change
without adjustment for follow-up period. The maximal
infrarenal aortic diameter at follow-up, the estimated
change per 5 years in aortic diameter and incident AAA
were the dependent variables in the regression models.
Carotid TPA and the estimated change in this variable per 5
years (DTPA) were the main explanatory variables. Change
was assessed as 2001 readings e 1994 readings. Known risk
factors for atherosclerosis and AAA were introduced as
covariates. We assessed the effect of atherosclerosis and
risk factors using a general linear model and logistic
regression (the GLM and LOGISTIC procedures in the SAS
statistical software). First, the age- and sex-adjusted mean
levels of cardiovascular risk factors and measures of
atherosclerosis at baseline were calculated in six categories
of maximal infrarenal aortic diameter at follow-up: <18,
18e20, 21e23, 24e26, 27e29 and 30 mm (see Table 2).
Linear trends across strata were tested by logistic regression
for categorical variables and by linear regression for
continuous variables (Tables 2 and 4). Linear and logistic
regression models were used to model the independent
relation between carotid atherosclerosis and aortic diam-
eter and AAA (Tables 3 and 5). In these models, baseline
TPA and DTPA were the main explanatory variables. Other
vascular risk factors were introduced as continuous or
binary variables in the model in order to adjust for con-
founding. We used the SAS statistical software package
Table 1. Characteristics of the study population.
Baseline (1994)
Age, y 59.4 (9.5)
Male sex, % 47.0
Systolic blood pressure, mmHg 143.3 (21.5)
Smoking, pack-years 11.0 (13.8)
Total cholesterol, mmol/L 6.69 (1.26)
HDL cholesterol, mmol/L 1.53 (0.44)
Diabetes, % 2.2
Lipid-lowering drugs, % 2.0
Anti-hypertensive drugs, % 11.1
Maximal infrarenal aortic diameter, mm 20.6 (2.7)
CHD present at baseline, % 9.5
Measures of atherosclerosis
Baseline TPA, mm2 8.4 (14.5)
DTPA estimated per 5 years, mm2 4.7 (11.7)
Values are unadjusted means (SD) or percentages.
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values were used throughout, and 95% conﬁdence intervals
computed.RESULTS
Mean (range) follow-up time was 6.3 (5.4e7.2) years.
Table 1 displays characteristics for the study population. The
mean carotid plaque growth (DTPA) per 5 years was
4.7 mm2 and the growth in maximal infrarenal abdominal
aortic diameter was 0.12 mm.
Table 2 shows the risk factor level at baseline stratiﬁed by
maximal infrarenal aortic diameter at follow-up. For age,
male sex, smoking and HDL-cholesterol, there were linear
doseeresponse relations with increasing aortic diameter.
There was also a linear increase in DTPA by increasing
abdominal diameter. Baseline TPA and CHD demonstrated
a J-shaped correlation to aortic diameter at follow-up
(Fig. 1). Baseline TPA was inversely correlated with aortic
diameter up to 27 mm; beyond this diameter TPA
increased, particularly in those with an AAA (maximalTable 2. Risk factor level at baseline stratiﬁed by maximal infrarenal a
Baseline characteristics Maximal infrarenal aortic d
<18
n ¼ 956
18e20
n ¼ 1433
Age,a y 58.2 58.6
Male sex,b % 20.6 38.2
Systolic blood pressure, mmHg 143.8 142.9
Smoking, pack-years 10.3 10.7
Total cholesterol, mmol/L 6.78 6.68
HDL cholesterol, mmol/L 1.54 1.55
Diabetes, % 2.6 2.0
Lipid-lowering drugs, % 4.2 2.0
Anti-hypertensive drugs, % 8.6 8.9
CHD present at baseline, % 12.8 10.8
Measures of atherosclerosis
Baseline TPA, mm2 9.1 8.6
DTPA estimated per 5 years, mm2 4.3 4.3
All values are age- and sex-adjusted. Percentages were adjusted by lo
a Adjusted for sex only.
b Adjusted for age only.infernal aortic diameter 30 mm). When stratifying the 5-
year aortic diameter growth into quintiles (not tabulated),
no doseeresponse relation was found for baseline TPA,
whereas for DTPA, male sex, smoking, HDL (inverse) and
diabetes (inverse) there appeared signiﬁcant trends.
Table 3 shows multivariable adjusted estimates of carotid
atherosclerosis for 5-year progression of aortic diameter
and aortic diameter at follow-up. Whereas no correlation
was found for baseline TPA, a 1-SD increase in 5-year DTPA
was correlated to a 0.12-mm (standard error, SE ¼ 0.04)
growth in aortic diameter in the multivariable model. The
multivariable analyses demonstrated no relationship with
baseline TPA, but a 1-SD increase in 5-year DTPA was
associated with a 0.20-mm (SE 0.06) larger aortic diameter
at follow-up. Thus, DTPA was independently related to
growth in aortic diameter as well as follow-up diameter.
The relationship between DTPA and change in aortic
diameter in the 2019 persons who had plaque progression
during follow-up is given in Fig. 2. In accordance with the
results from linear regression (Table 3), there was a strong
positive relationship between plaque growth and growth in
infrarenal aortic diameter (p < 0.0001).
During follow-up there were 130 incident cases of AAA,
deﬁned as maximal infrarenal aortic diameter 30 mm.
Table 4 shows quintiles of 5-year change in aortic diameter
in these 130 individuals. Both for DTPA (but not baseline
TPA) and baseline CHD prevalence there were positive
doseeresponse trends with increasing aneurysmal diam-
eter. However, in multivariable linear regression models,
DTPA was associated neither with 5-year growth in aortic
diameter nor aortic diameter at follow-up (results are not
shown in the tables). Another two participants had under-
gone surgery between the two screenings because of an
incident AAA. Their maximal infrarenal aortic (graft) diam-
eter at follow-up was 19.5 and 29.5 mm, respectively. In
a multivariable logistic model including all 132 persons with
AAA, a 1-SD increase in baseline TPA and a 5-year DTPA was
associated with 15% (odds ratio 1.15, 95% conﬁdenceortic diameter at follow-up.
iameter at follow-up, mm p-Trend
21e23
n ¼ 1129
24e26
n ¼ 461
27e29
n ¼ 132
30
n ¼ 130
59.7 61.2 62.8 63.5 <0.01
59.5 78.5 83.0 79.3 <0.01
143.9 141.8 142.6 145.4 0.8
10.4 11.6 14.9 18.7 <0.01
6.65 6.57 6.83 6.94 0.7
1.54 1.49 1.47 1.39 0.0002
1.6 1.8 1.1 2.3 0.2
1.4 1.4 3.1 7.2 0.8
9.4 10.3 7.2 10.5 0.4
9.2 7.6 12.7 17.6 0.9
7.7 6.9 9.3 12.5 0.9
4.9 5.1 6.7 7.9 0.0006
gistic regression. Means were adjusted by ANOVA.
Table 3. Carotid atherosclerosis in relation to 5-years change in maximal infrarenal aortic diameter and maximal infrarenal aortic diameter
at follow-up.
Dependent variable Main explanatory variable ba SE p
5-years change in maximal infrarenal aortic
diameter
Baseline TPA, mm2 0.01 0.05 0.74
5-years change in maximal infrarenal aortic
diameter
DTPA estimated per 5 years, mm2 0.12 0.04 0.0062
Maximal infrarenal aortic diameter at follow-up Baseline TPA, mm2 0.08 0.06 0.18
Maximal infrarenal aortic diameter at follow-up DTPA estimated per 5 years, mm2 0.20 0.06 0.0008
The models were adjusted for age, sex, systolic blood pressure, total cholesterol, HDL-cholesterol, pack-years of smoking, diabetes mellitus,
anti-hypertensive- and lipid-lowering medication.
a Values are regression coefﬁcients (SE) expressed in mm for 1-SD change in baseline TPA and DTPA.
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0.99, 1.32), respectively, increased odds for having AAA at
follow-up. The relationships were both of borderline
statistical signiﬁcance, however (Table 5).When additionally
adjusted for baseline infrarenal aortic diameter, a strong
and independent predictor of AAA,21 the estimates were
reduced somewhat and did not reach statistical signiﬁcance.DISCUSSION
When modelling aortic diameter as a continuous variable,
we found that progression of carotid atherosclerosis (DTPA)
was related to growth in infrarenal abdominal aortic
diameter as well as follow-up diameter both in those with
and without incident AAA. However, for baseline athero-
sclerosis the relationship was more complex with no linear
correlation to aortic growth, but an increased plaque
burden was seen in persons with the widest aortic diame-
ters at follow-up (27 mm). In the fully adjusted models,
however, no independent relation was found between
baseline atherosclerosis and aortic diameter. An explanation
for this discordance between baseline TPA and DTPA couldTable 4. Measures of atherosclerosis and risk factor levels in strata
(n ¼ 130).
I
n ¼ 26
5-years change in maximal infrarenal aortic
diameter, mm
3.09
Maximal infrarenal aortic diameter at
follow-up, mm
30.91
Baseline TPA, mm2 22.3
DTPA estimated per 5 years, mm2 4.7
Baseline femoral lumen diameter, mm 6.75
DFemoral lumen diameter estimated per
5 years, mm
1.18
Baseline CHD, % 9.0
Age, years 64.8
Male sex, % 98.0
Baseline smoking, pack-years 17.3
Baseline total cholesterol, mmol/L 6.84
Baseline HDL cholesterol, mmol/L 1.28
Baseline systolic blood pressure, mmHg 149.7
Baseline diabetes, % 1.2
Baseline lipid-lowering drugs, % 11.2
Baseline anti-hypertensive drugs, % 11.4
All values, except for age and sex, are age- and sex-adjusted.Age wasbe that atherosclerosis in its initial stages has less impact on
abdominal aortic dilatation, but as the dilatation process
proceeds, atherosclerosis becomes more important.
However, neither in those with the highest aortic growth
rate, the 130 subjects who developed an AAA during follow-
up, could we demonstrate any linear relationship between
baseline atherosclerosis and aortic diameter.
There is an ongoing discussion whether atherosclerosis is
causally related to AAA formation.
There exist plausible hypotheses for how aortic dilatation
is linked to atherosclerosis. Both aneurysmal dilatation and
atherosclerotic plaque formation are complex remodelling
processes with disturbances in synthesis and degradation of
matrix proteins. Initially, atherosclerosis is an intimal
disease, but the tunica media and adventitia may second-
arily either dilate to preserve the lumen (expansive
remodelling) or shrink and thus aggravate the obstruction
caused by plaque formation (restrictive remodelling).22,23 In
the severe forms of atherosclerosis, either progressive
dilation (aneurysmal formation) due to expansive remod-
elling,24e26 or diffuse narrowing of the aortic lumen asso-
ciated with chronic ischaemia of the lower limbs,27 mayof 5-years change in infrarenal aortic diameter in incident AAA
II
n ¼ 26
III
n ¼ 26
IV
n ¼ 26
V
n ¼ 26
p-Trend
4.78 5.94 7.75 11.88
31.95 31.76 34.05 39.15 <0.0001
14.2 11.3 14.4 14.1 0.2
8.0 8.2 7.7 15.5 0.03
8.23 7.86 7.45 7.60 0.5
0.31 0.78 0.46 0.72 0.4
16.6 26.1 19.8 36.2 0.03
61.8 64.2 62.8 60.3 0.06
68.2 79.5 70.0 72.7 0.058
19.1 19.9 27.2 21.7 0.09
6.99 6.95 7.00 7.10 0.5
1.42 1.32 1.32 1.30 0.8
145.8 151.2 150.2 146.1 0.9
3.3 4.7 3.9 2.3 0.7
7.8 4.8 8.4 2.3 0.3
19.4 6.6 14.8 21.0 0.5
adjusted for sex and sex was adjusted for age.
Table 5. Carotid atherosclerosis as predictors and risk for incident
AAA.a
Dependent
variable
Model I Model II
ORb p ORb p
Baseline TPA, mm2 1.15
(1.01e1.32)
0.04 1.12
(0.97e1.29)
0.1
DTPA estimated
per 5 years, mm2
1.14
(0.99e1.32)
0.08 1.08
(0.92e1.26)
0.3
Model I was adjusted for age, sex, systolic blood pressure, total
cholesterol, HDL-cholesterol, pack-years of smoking, diabetes
mellitus, and anti-hypertensive- and lipid-lowering
medication.Model II was additionally adjusted for baseline
maximal infrarenal aortic diameter.
a 132 Persons with AAA were included in analyses.
b OR for having AAA for 1-SD increase in baseline TPA or DTPA.
Figure 2. Age- and sex-adjusted 5-years change (SE) in infrarenal
aortic diameter by strata of 5-year total carotid plaque growth
(DTPA) (n ¼ 2019).
S.H. Johnsen et al. 139occur. The J-shaped correlation between baseline TPA and
maximal infrarenal aortic diameter at follow-up (Table 2)
may indicate that atherosclerosis in its initial stages has
little impact on abdominal aortic dilatation, but as the
atherosclerotic process progresses, it becomes more
important as also suggested by the results displayed in
Fig. 1. However, if the hypothesis was true, one should
expect plaque burden in 1994 to predict aortic diameter in
2001, but in this study this is not the case. Even if many AAA
researches consider atherosclerosis as a needed initiating
factor, our ﬁndings could simply indicate that atheroscle-
rosis and aortic growth progress in parallel but through
different and partly independent processes due to shared
risk factors.
Other studies looking into the qualitative aspects of
atherosclerosis reported lipid laden (soft) plaques to be
associated with expansive remodelling of the vessel and
arterial dilation, which could be related to the formation
of an aneurysm.26 Conversely, in cases with more ﬁbrous
and calciﬁed plaques, the increased rigidity of the aortic
wall would prevent compensatory dilation, thus facili-
tating the obliterative form of the disease.26 TheseFigure 1. Age- and sex-adjusted baseline total carotid plaque area
(TPA) and prevalence of CHD in strata of aortic diameter at follow-
up (n ¼ 4241).ﬁndings may imply that the qualitative aspects of
atherosclerosis (plaque morphology), more than the
extent of atherosclerosis, play a role in aortic dilatation
and aneurysmal formation.
The main limitation of our study is the inter- and intra-
observation variability. In studies on progression, the
measurement errors of at least two measurements are
accumulated, giving substantially lower statistical power
compared to baseline measurements only. We have pre-
sented the aortic diameter estimates without adjustments
for baseline aortic diameter. Adjustments for baseline
values of the dependent variable without correction for
measurement error may introduce bias that leads to an
overestimation of the risk estimates.28 The possibility of
regression towards the mean must also be considered in
this study.29 In fact, those having the largest aortic diameter
and plaque burden at baseline had the lowest growth rate
and vice versa.
The strength of the study is that atherosclerosis was
assessed directly by ultrasound in the carotid artery, which
is a representative measure of the global burden of
atherosclerosis,30 and that it is population based and
prospective over a time period of 6 years. The attendance
rate at baseline was high (79% of the eligible population).
Furthermore, 78% of the individuals who had their aortas
examined in 1994 and were alive and living in Tromsø in
2001 had a follow-up ultrasound examination. Carotid and
abdominal ultrasonography were performed in 75% of the
eligible population, where the majority of subjects were
aged 55e74 years. The attendance rate in those older than
74 years was only 58%, and this is of some concern as this
age group has the highest prevalence of AAA and athero-
sclerosis. However, given that the association between
atherosclerosis and aortic diameter does not differ between
the not examined and the scanned group, this will not
inﬂuence the strength of the associations.
In summary, when analysing aortic diameter as a contin-
uous variable, carotid plaque growth, but not baseline
atherosclerosis, was independently related to growth in
abdominal aortic diameter and follow-up diameter.
Whether the co-variation between plaque growth and
aortic diameter growth is causally related or independent
events is still an open question.
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